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SUMMARY 
Six patients with terminal uremia due to 
glomerulonephritis or pyelonephritis were 
treated with heterografts from East African 
*Reproduced, with permission. from Transplantation 
(1964) 2, 752-m 
.. Although we predicted from the 
ReemtsmalHitchcock experience that 
the baboon kidneys would not be hyper-
acutely rejected, the specter of more 
subtle antibody rejection hung heavily 
over the trials, prospectively and after-
wards. It would be another year before 
hyperacute rejection associated with 
Iymphocytotoxic antibodies was recog-
nized in ABO-compatible allograft recipi-
ents I. Consequently, a study of such 
antigraft antibodies was not done. 
Instead, attention was focused by David 
Talmage's immunology fellows (Charles 
Kirkpatrick and W E C Wilson) on the 
effect of hetero(xeno)specific hemagglu-
tinins. 
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baboons. Immunosuppressive therapy was 
provided both before and after operation 
with azathioprine and prednisone and post-
operatively local transplant irradiation and 
actinomycin C were administered intermit-
tently. The individual rejection episodes in 
the post-transplant period could be 
reversed relatively easily but these recurred 
The baboon xenografts functioned 
for a mean of 41 days when there was 
ABO compatibility (n = 3) versus 21 
days when there was not (n = 3). 
Although this suggested an important 
ABO effect, there was serologic evi-
dence that xenospecific hemagglutinins 
also bound to the transplanted kidneys 
in every case. It appeared from the clini-
cal observations, and especially from 
Porter's histopathologic analyses, that 
humoral xenograft rejection was uncon-
trollable with cell-directed immune sup-
pression. even in the phylogenetically 
close baboon-to-human combination. 
Therefore, we concluded that, "until 
improved methods of management 
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vigorously and repetitively, making it impos-
sible to relax the stringent requirements of 
antirejection therapy. The continued need 
for high-dose immunosuppressive therapy 
precipitated lethal infections in the majority 
of cases. 
The patients lived for 19 to 98 days 
after heterotransplantation. Four died with 
the baboon kidneys still in place after I 9, 
23, 35, and 49 days. In the other two 
cases the heterogra(ts were removed after 
60 and 49 days respectively, at a time 
when urine excretion was still present, and 
homograf/:s from volunteer convict donors 
were placed on the opposite side. Both the 
latter recipients died of septic complications 
following the second operation, after 39, 
and 44 days. Complete cessation of hetero-
groft urine excretion appeared only in two 
cases, although renal function was failing in 
the remainder prior to death or before 
removal of the heterografts. The relation of 
the renal function to changes in the het-
eroagglutinin and hemagglutinin titers is 
described. 
After residence in the host for 19 to 60 
days, all the heterotransplants were heavily 
infrltrated with plasma cells and large lym-
phoid cells with pyroninophilic cytoplasm. 
There was also disruption of peritubular 
capillaries, interstitial edema, widespread 
tubular damage, swelling of endothelial cells 
lining arterioles, frbrinoid n~crosis of the 
walls of arterioles and interlobular arteries 
by fibrin and platelet deposits on the 
become available, further trials do not 
seem justified, and none are contemplat-
ed by us until that time". The moratori-
um lasted more than 28 years until our 
two laboratory-based attempts at 
baboon-to-human liver transplantation 
of 1992-93. These also failed because of 
a less obvious humoral rejection, but 
with unmistakable complement activa-
tion despite complete freedom from cel-
lular rejection out to 70 days. As in 
1964, the rejection of 'concordant' 
xenografts was a 'slow motion' version 
of that seen with 'discordant' 
xenografts2. It was time for a new mora-
torium. 
The humoral component of .. 
CLASSICS 
Xeno December 1996 
intima. The pre-glomerular vascular lesions 
were accompanied by focal infarctS and 
extensive interstitial hemorrhages. All the 
pathologic changes were more severe then 
those seen by Reemtsma in comparable 
series of chimpanzee-ta-man heterotrans-
plants, where cellular infihration was slight 
and vascular lesions uncommon in the pres-
ence of major blood group incompatibility 
between donor and recipient 
During the developmental era of vascular surgery, five clinical 
renal heterotransplantations are 
known to have been tried, each with a 
different type of animal donor 
(4,7,16,19). Significant renal function was 
not obtained in any instance, and the 
longest survival was 9 days. No addi-
tional attempts at heterotransplantation 
were made in the ensuing 40 years, and 
the tacit assumption became firmly 
entrenched that such avenues of investi-
gation presented insurmountable biolog-
ic difficulties. 
In 1963, Reemtsma (12,14) and 
Hitchcock (2) and their associates re-
examined the possibility that heterograft 
function could be obtained and sus-
tained with the aid of various immuno-
suppressive agents. It was established 
that immediate urine excretion of chim-
panzee (12-14), rhesus monkey (12), 
and baboon kidneys (2) followed after 
transplantation to the human, and that 
~ xenograft rejection was discussed in our 
1964 article as an Arthus reaction, the 
same term (or alternatively 'Shwartzman 
reaction') used to described hyperacute 
allograft rejection in patients who had 
preformed antigraft cytotoxic antibodies 
(classical pathway of complement activa-
tion) but also in exceptional patients 
who were antibody free (alternative 
pathway)3. Thus, it was recognized 
almost from the beginning that humoral 
rejection of allografts under specific cir-
cumstances and that of xenografts 
involved an acute inflammatory reaction 
that would not yield to conventional 
immune suppression. 
John Najarian, in commenting 30 
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maintenance of relatively protracted 
chimpanzee heterograft function could 
be expected at least in the occasional 
case. 
The present study is an account of a 
clinical study of renal heterotransplanta-
tion carried out at the University of 
Colorado Medical Center in December. 
1963, and January, 1964, using baboons 
for donors. By comparison of the 
results with those previously obtained 
with homotransplantation (17) it was 
hoped to define the differences and sim-
ilarities of homograft and heterograft 
behavior in the human host. In addition, 
it became possible as the result of an 
exchange of functional and pathologic 
data with Reemtsma to arrive at tenta-
tive conclusions concerning the biologic 
suitability for human heterograft dona-
tion of different subhuman primates. 
Results 
Clinical course. Four patients died 
with baboon kidneys still in place [1]. In 
Cases 3 and 4, the heterografts were 
removed after 60 and 49 days respec-
tively, and homografts from volunteer 
convict donors were placed on opposite 
side. Survival after the second operation 
was 39 days in Patient 3 and 44 days in 
Patient 4. Complete cessation of het-
erograft excretion occurred only in 
Cases 2 and 5 (Table 3 [not shown]), 
although renal function was failing in the 
years later on his own classical studies'\ 
has pointed out how little progress has 
resulted from the cyclic 'rediscovery' of 
the pathogenesis of xenograft rejection, 
and of treatment strategies, using 
increasingly sophisticated technologies 
to delineate what was already quite obvi-
ous by the late 1960s. An exception to 
the futility was the recognition by Gus 
Dalmasso and Fritz Bach that the seminal 
problem of complement activation could 
be resolved by providing the target 
donor tissues with complement regula-
tory peptides of the recipient species. 
This objective was achieved when 
'humanized' transgenic animals were 
produced by David White in England and 
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remainder prior to death (Patients I 
and 6) or before removal of the trans-
plant (Patients 3 and 4). All patients 
exhibited a marked early clinical 
improvement at the time of initial diure-
sis and for varying periods thereafter. 
Recovery was, however, interrupted in 
each instance except Patient I by early 
rejection crises, which were character-
ized by transplant site tenderness, and 
by multifaceted evidence of acute renal 
failure. The timing of the rejection 
episodes is indicated in Table 4 [not 
shown] and the influence upon renal 
function is graphically portrayed in Fig-
ures 2-4 [not shown]. 
Ultimately, each of the last five cases 
became unmanageable because of the 
repetitive and closely-spaced rejections. 
Although the individual crises could be 
at least partially controlled in most 
instances, with local transplant irradia-
tion, actinomycin C or increases in 
steroid dosage, the adverse conse-
quences could not be completely 
reversed before the onset of the next 
assault. The cumulative effect was pro-
gressive deterioration, interrupted by 
incomplete remissions. In Patients 3 and 
4, removal of the heterografts was pre-
cipitated by the sudden formation of 
masses in the transplant areas, of such 
magnitude in Case 3 as to produce mas-
sive edema of the right leg which was 
apparently due to local compression of 
by John Logan in the USA with the col-
laboration of Jeffrey Platt and other col-
leagues. With this progress in cracking 
the shell of the xenotransplant problem, 
what remains to be done is the induc-
tion of organ acceptance by the same 
chimerism-dependent mechanisms that 
have spawned successful allotransplanta-
tion5. 
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the venous and lymphatic systems. At 
the same time of extirpation, the 
swollen and boggy heterografts were 
surrounded with 500 to 1000 cc 
serosanguineous fluid under consider-
able pressure. \ 
Because of the intensity and ~erse­
verance of rejection, it was not possible 
to successfully relax the magnitude of 
immunosuppressive measures. Every 
attempt to reduce prednisone was fol-
lowed by serious rejection. The pro-
longed use of doses in excess of 100 
mg/day resulted in profound hypercorti-
cism. Three of the six patients devel-
oped steroid diabetes and one required 
treatment with insulin. The extraordi-
nary degree of immunosuppression 
required to maintain even mediocre 
renal function undoubtedly contributed 
to the septic complications which played 
a role in the unfavorable outcome of all 
but Patient 5. In Cases 3 and 4, in which 
homografts were ultimately used to 
replace the excised baboon kidneys, the 
protracted initial course of stringent 
anti rejection therapy appeared to have 
jeopardized the prognosis for the same 
reason, since sepsis was a terminal event 
in both patients. Patients I and 2 had 
early pulmonary emboli with infarction 
and abscess formation. Resection of the 
lower lobe and lingula was· performed in 
Case 2 in an attempt to eliminate this 
septic focus. The sources of venous 
anastomoses. Those patients receiving 
heterografts from baboons with compat-
ible blood types had more sustained 
function than those which did not. 
(Table 2) [not shown]. 
The alternations in renal function 
(Fig. 2-4) were similar to those which 
characterize homograft repudiation (17). 
Urine volume fell. Sudden rises in BUN 
and serum creatinine occurred with 
declines in creatinine clearance. The par-
tial reverSibility of these changes was 
encouraging. In many instances (Table 4), 
this was accomplished with the com-
bined use of actinomycin C and local 
irradiation. The efficiency of each of 
these agents alone was also demonstrat-
ed on other occasions (Table 4), the 
most clear-cut benefit being with local x-
ray therapy (Figs 2, 4). In Cases 4 and 6, 
secondary diuresis occurred with vol-
umes as high as 7870 and 4750 ml (Fig. 
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3,4) [not shown]. The relative ease with 
which partial remission was achieved 
was misleading. Functional restoration 
was either short-lived or incomplete. 
The shortest interval between the first 
and subsequent rejection crisis was 3 
days; the longest was 45 days (Fig. 2). 
Between these dramatic occurrences, 
there was frequently a subtle diminution 
in function (Figs 2-4). Patients 2 and 5 
ultimately became anuric. The last creati-
nine clearance measured in Cases I, 3, 4 
and 6 before removal of the heterografts 
or death of the patients were 59.8, 16.1, 
25, and 14.8 mllmin. 
In addition to the other features of 
rejection described above, a consistent 
alteration of urinary composition was 
observed. A sharp decrease in urinary 
sodium and chloride concentration 
accompanied the relative oliguria of the 
rejection episode (Figs 2, 3) in every 
instance (Table 7 [not shown]). A con-
comitant increase in urinary urea nitro-
gen concentration was usually observed. 
With reversal of rejection, the dimin-
ished sodium excretion tended to return 
to the previous level at the same time as 
improvement occurred in urine volume, 
creatinine clearance, and BUN. That 
none of these alterations is a unique fea-
ture of heterografts was evident from 
the fact that similar changes were 
observed in Case 4 during a single rejec-
tion after placement of a homograft. 
Infectious Complications. A variety 
of infections were observed before and 
after heterotransplantation (Table 8 [not 
shown]). Those occurring after institu-
tion of immunosuppression was started 
were effectively treated. Those occur-
ring after institution of immunosuppres-
sion were not affected by antibiotic ther-
apy, the infectious complication 
contributing to 5 of the 6 deaths (Table 
8). It had been pointed out previously 
(15) that several consequences of 
immunosuppressive therapy summate to 
render the patient abnormally suscepti-
ble to infectious complications. These 
effects were apparently magnified in the 
heterotransplantation cases in which 
maximal suppressive therapy was 
required for even temporary survival of 
the grafted organ. The extreme degree 
of immunosuppression was reflected by 
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the presence of significant leukopenia 
(3000/mm3 or less) in three patients, 
hypogammaglobulinemia (600 mg% or 
less) in two, and glycosuria in three. It is 
probably for these reasons that only one 
of the six known bacterial infections 
occurring after the institution of 
immunosuppression was controlled. 
Antibiotic therapy may have contributed 
to development of systemic fungal infec-
tions. 
Gross Pathologic Studies. The 
baboon kidneys were all enlarged, with a 
mean weight of 108 gm. This increase 
was greatest (180 gm) in Case 2. where 
function ceased at 25 days following an 
irreversible phase. and least (65 gm) in 
Case I. where the patient had never 
experienced a clinically recognizable 
rejection episode and where the creati-
nine clearance was still 59.8 ml/min 
hourly before the patient died from a 
pulmonary embolus. 
The capsules were a little thickened 
and stripped easily. In Case I the sub-
capsular surfaces were smooth. light 
brown and speckled with petechial hem-
orrhages; when cut, the kidneys bulged 
slightly and there was some blurring of 
the corticomedullary junction. The kid-
neys from Case 5 were a uniform red-
dish purple and it was not possible on 
the cut surfaces to differentiate between 
cortex and medulla. However. the other 
four pairs of transplants were mottled 
with irregular blotchy hemorrhages. 
measuring up to 0.5 cm in diameter. and 
paler yellOWish infarcted areas which 
were each surrounded by a bright red 
zone several millimeters wide (Fig. 12 
[not shown]). There were also scattered 
petechial hemorrhages. The cut surfaces 
of these kidneys bulged and similar hem-
orrhagiC and paler areas were seen in 
the cortex and extending in the cortex 
and extending into the deep red medulla. 
The main renal artery and vein were 
patent in all cases. although the blind 
pouch of baboon aorta was filled with 
laminated thrombus in Case 2. The right 
kidney from Patient I was surrounded 
by a large hematoma which might have 
caused some compression of the renal 
artery on that side. The ureters had 
swollen. often hemorrhagic walls. with 
narrowed by patent lumens. There were 
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petechiae in the calyces and renal pelves. 
Microscopic Pathologic Studies. All 
the transplanted kidneys were heavily 
infiltrated by cells (Figs 13, 14 [not 
shown]). This was most pronounced in 
Cases I and 3 and least obvious in Case 
6. The cells, which were found predomi-
nantly in the cortex, were distributed in 
a patchy fashion in four of the pairs of 
transplants, but in Patients I and 4 they 
were scattered diffusely throughout the 
interstitium. Many were plasma cells and 
some of these possessed two or even 
three nuclei. Others were cells with 
varying amounts of pyronin-positive 
cytoplasm and large pale nuclei, with 
prominent nucleoli. In Case I occasional 
such cells were in mitosis. There were 
also a few small lymphocytes, and in 
Cases I and 3 eosinophils were fre-
quent. Phagocytic cells which looked like 
lupus erythematosus (LE) cells, were 
present in small numbers in the intersti-
tium of Cases 2 and 3. Some erythro-
phagocytosis was seen in the transplants 
from Patient I. Interstitial edema was a 
feature of all these heterotransplants 
(Fig. 14). It was most severe in the heavi-
est kidneys which were those from 
Cases 2 and 3. Scattered focal interstitial 
hemorrhages were present in all of the 
heterotransplants and accounted for 
many of the red blotches seen grossly. 
Although they were infrequent and small 
in the kidneys from Case I, they were 
widespread and large in Cases 3 and 4. 
Focal small infarcts, while present in all 
the transplants, were least apparent in 
patients I, 3 and 4 where function termi-
nally had been fair and whose last creati-
nine clearances ranged from 16.1 ml to 
59.8 ml/min. Some of the infarcts were 
hemorrhagic (Fig. 15 [not shown]). 
Almost total infarction was present in 
Case 5. Peritubular capillary destruction 
was widespread in all the cases (Fig. 14). 
Surviving capillaries usually contained 
marginating pyroninophilic and lymphoid 
cells. Swelling of the endothelial cells lin-
ing the afferent arterioles was obvious in 
three of the pairs of kidneys. 
In four of the transplants there was 
focal fibrinoid necrosis of the walls of 
the interlobular arteries and arterioles 
(Fig. 16 [not shown]). There may also 
have been similar changes in Case 5 but 
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widespread infarction made interpreta-
tion of vessel changes impossible. Rup-
ture of the internal elastic lamina of 
affected vessels was common. Case I 
showed no vasculonecrotic lesions. Fib-
rin and platelet deposits on the intima of 
interlobular arteries were seen in all the 
transplants and caused narrowing of 
variable number of the vessels. Blockage 
of some lumens was completed by 
superimposed thrombus. In Case 2 
replacement of the fibrin-platelet 
deposits by fibroblasts had occurred 
with breakdown of the platelets to leave 
fat droplets in the deeper parts of the 
occluding layer. Obvious secondary 
thrombosis of large arteries and veins 
was present in the two pairs of hetero-
transplants which ceased functioning 
many days before death of the patient 
(Cases 2 and 5). 
Tubular necrosis with evidence of 
regeneration was present in all the cases. 
This was most severe and widespread in 
Patients 2, 3 and 6. Casts of protein and 
cell debris were frequent. There was 
also some red cell and pigment casts. 
The glomeruli were relatively well pre-
served. There was some hypertrophy of 
the tufts and prominent granularity of 
the juxtaglomerular cells in the pair of 
transplants that functioned for 60 days 
(Case 3). Hyperplasia and increased 
granularity of the juxtaglomerular body 
was present in the one case (Patient 4) 
in which hypertension had been present 
during the postoperative course. 
Discussion 
The present study was designed to 
thoroughly test the feasibility of renal 
heterotransplantation from baboon to 
man, with the best therapeutic regimen 
currently available. This objective was 
met. There was no surgical mishaps. 
Each of the heterografts was inserted 
under ideal technical conditions. 
Although the transplanted tissue was not 
weighed at the time of operation, it was 
predicted from previous ratio determi-
nations of renal weight/total body weight 
that the total renal mass ranged from 32 
to 82 gm, half or less than that of a sin-
gle human kidney. 
The primary cause of failure in all but 
one case was inability to control rejec-
tion. When other non renal complica-
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tions supervened, most were related to 
the need for continuous high-dose 
immunosuppressive measures. Generally 
severe pathologic changes were present 
in the heterotransplants. The cellular 
infiltration was heavier than that seen in 
any of the homografts from the Universi-
ty of Colorado renal homotransplanta-
tion series (9), which were removed or 
recovered at autopsy. In Cases I and 3 
the infiltrate approached in severity that 
seen in canine homotransplants. The 
accompanying widespread damage to 
peritubular capillaries had resulted in 
extensive tubular necrosis. Arterial and 
arteriolar interstitial hemorrhages. Even 
the kidneys from Case I, where no 
rejection episode was detected, showed 
heavy cellular infiltration, damage to per-
itubular capillaries and early patchy tubu-
lar necrosis. Under the circumstances of 
this study, chronic survival after baboon-
to-man transplantation seems, therefore, 
to be a virtual impossibility. Unless 
improved methods of management 
become available, further trials do not 
seem justified and none are contemplat-
ed by is until that time. 
The recent use of other subhuman 
primates allows some tentative conclu-
sions concerning the relative biologic 
suitability of simian donors for human 
heterotransplantation. From a pathologic 
point of view, the vigor of the immuno-
logic reaction has seemed to be much 
less with chimpanzee tissue, in contrast 
to baboon and rhesus monkey hetero-
transplants which evoke a fierce 
response on the part of the human host 
(9). In this connection, it is noteworthy 
that one patient treated by Reemtsma 
with paired chimpanzee heterografts has 
essentially normal renal function 22 
weeks after operation. 
It was pointed out earlier that 
baboon heterograft rejection was not 
overtly different in many respects from 
that commonly observed with homo-
grafts. The differences were quantitative 
in that repudiation of the alien tissue was 
more vigorous and insistent. Despite the 
simil,arities it is pertinent to consider 
that' the rejection of heterografts may 
involve immunologic pathways different 
from those of homografts. Specifically, it 
might be expected that circulating free 
antibodies could playa dominant role. In 
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laboratory experiments with cross 
species transplantation. destruction of 
whole organ heterografts ha,s been 
observed to occur with such rapidity 
(within minutes or hours) that ,only a 
humoral mechanism could provid~ a sat-
isfactory explanation (I). The immediate 
consequences in these experiments 
were indistinguishable from those which 
have been observed in two human cases 
in which homografts were transplanted 
between donors and recipients of 
incompatible blood types (17). and in an 
A to 0 chimpanzee-to-human hetero-
transplantation performed by Reemtsma 
(14). Since all six patients in the present 
study had preformed heteroagglutinins 
directed against baboon erythrocytes. it 
is surprising that a similar immediate 
repudiation did not occur. particularly 
since measurable heteroagglutinins dis-
appeared entirely from the peripheral 
blood at some time during the postoper-
ative course in each case. 
Except as a general index of 
immunologic activity. the significance of 
the changes in host heteroagglutinins. 
and their cyclic variation during rejection 
episodes. is not known. The disappear-
ance of heteroagglutinins from the 
peripheral blood indicated that antigenic 
determinants specific for this serum anti-
body were present on the renal cells. 
The later rises in titer could be 
explained by an intensification of anti-
body formation accompanied by satura-
tion of all available binding sites within 
the kidney. The possibility receives some 
'·'7'·-
support from the fact that the increases 
in heteroagglutinin titers tended to 
occur at the same time as the acute 
rejection episodes. 
There are a number of possible 
explanations for the failure to observe 
immediate rejection in the presence of a 
preformed antibody directed against the 
heterograft. Stetson and Demopolous 
(18) have postulated that an intrarenal 
Arthus reaction is the effector pathway 
mediating humoral rejection. Since the 
intensity of the Arthus reaction is a func-
tion of the concentration of bivalent 
antibody (10). it is conceivable that the 
quantity of recipient heteroagglutinin 
was insufficient to saturate all the anti-
genic sites on the kidney cells. The total 
disappearance of the heteroagglutinins is 
evidence in favor of this. Finally. it is pos-
sible that the release of chemical effec-
tors of rejection. perhaps because a final 
step of the reaction was blocked by 
immunosuppressive therapy. 
It is impossible to be certain from 
present evidence if there is any funda-
mental difference in the mechanism of 
rejection in these heterografts as 
opposed to homografts. With hetero-
grafts. both humoral and cellular ele-
ments seem to play a role. With homo-
grafts. the principal emphaSiS in the past 
2 decades has been directed to the con-
cept of cell-mediated rejection. primarily 
because of the paucity of evidence impli-
cating measurable serum factors. More 
recently the potential role of humoral 
component of homograft rejection has 
vOlume 'f numDer 0 
received increasing support from several 
lines of evidence (3.6,11.17). The differ-
ences between heterograft and homo-
graft rejection may. therefore. be more 
apparent than real. 
Another hemagglutination system 
was studied which has immediate practi-
cal importance since it influences donor 
selection. It was pointed out in the 
"methods" section that A and B antigens 
are not detectable in baboon erythro-
cytes for which reason the animals were 
blood typed with salivary tests and by 
the presence of reciprocal hemagglu-
tin ins (21). The alterations in specific 
anti-A and anti-B titers provide evidence 
that these antigens do not exist in renal 
tissue despite their absence on the red 
cells. a situation comparable to that 
described by Weiner and his associates 
(20) for the Rhesus monkey. 
The marked changes in titer after 
heterotranspla.ntation of AB blood type 
mismatches and the absence of this find-
ing in the compatible cases is strong evi-
dence of hemagglutinin binding by the 
heterograft. As with the heteroagglu-
tinins, this did not prevent immediate 
function, which survival was not as long 
and the quality of renal function was a 
slightly lower level in the mismatched 
group. It would. therefore. be consid-
ered inadvisable in the future clinical 
investigations of heterotransplantation 
to accept such incompatible donor-
recipient combinations. 
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